Posts Tagged ‘pharma’

Pretty bad and pretty funny. That’s how I’d summarize what the websites looked like for these 13 biopharma, medical device, and research organizations when they first made their mark on the World Wide Web. In honor of Throwback Thursday, we used Internet Archive’s Wayback Machine to poke fun at the companies many of us have come to […]

Just kidding. You may have read the story on TMZ of a New York businessman making big bucks off the panic surrounding Ebola. Guess what? The FDA hit him where it hurts. His site is down. Stop trying to trick the public. Stop being sleazy. That’s the message the FDA is sending to pharmaceutical, medical […]

It’s no secret that validation can be a bear. All of that documentation and testing, the multiple phases with pesky transition gates, a million reviews and approvals…it can really slow down an IT project, which often leads to questions about why on Earth we bother with it. Well, it all traces back to rules and regulations […]

The other day, I was watching Cory Johnson interview Bryson Koehler, CTO and CIO of The Weather Company, on Bloomberg West. While the talk focused on The Weather Company’s business model, I thought several points during the discussion were quite relevant to life sciences companies. Frankly, they’re applicable to most industries. The Weather Channel, which […]

We’re all users of software. Put us in front of two systems – one that looks outdated and unorganized, and one that looks good and structurally makes sense – and I bet you’d gravitate to the latter one. In fact, although I didn’t conduct a poll, I’m sure we’d all choose the latter. It’s not […]

I recently heard a segment on the radio about personalized medicine. Or “translational medicine.” Or “translational research.” Or “precision medicine.” Whatever you want to call it! Dr. Murray Feingold, a pediatrician and geneticist in the Boston area, painted a clear description of the term. He put it in words that all of us can understand. […]

On November 6, 2014, Canada passed Vanessa’s Law, a new piece of legislation designed to protect patients from unsafe drugs and medical devices. The law comes after many complaints from citizens that the country wasn’t doing enough to oversee the safety of products sold in the marketplace or the clinical trials being conducted in the […]

Digitally signing documents is easier than you might think. It’s also much faster than having to print, sign, and scan them. And, of course, there’s a significant cost-savings for companies that frequently mail and store hardcopy documents. A product like CoSign can be a great solution for companies, especially those in highly-regulated industries that require […]

What do our pharmaceutical product advertisements indicate about our national ideals, given the myriad of advertisements seen on the Internet, TV, in magazines, or heard on the radio here in the United States? Interestingly, the United States and New Zealand are the only developed nations that allow direct -to-consumer (DTC) advertising (Liang & Mackey, 2011). […]

Senior Management is always looking for answers about what works, what doesn’t, and how best to design and manage clinical trials. In order to get those answers, all of your trial data needs to be in one place and in a consistent format – this is the only way to extract accurate information. But, how […]

There’s a clear trend in the life sciences industry toward outsourcing clinical trial management to clinical research organizations (CROs). If you decide to join the movement, how should you go about getting data from your CROs into your clinical trial management system (CTMS)? The most common method is to collect reports from CROs in the […]

The benefits of minimally invasive surgeries (MIS) are clear: fewer complications, shorter lengths of hospital stays, fewer readmissions, and lower total costs. However, the adoption rate for MIS is surprisingly low. A large medical device client of ours discovered that fewer than 30% of the tens of millions of potential procedures (of interest to them) […]